| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Journal of the American Society of Nephrology, Vol 5, 2057-2066, Copyright © 1995 by American Society of Nephrology
REGULAR ARTICLES |
R Zietse, FH Derkx, W Weimar and MA Schalekamp
Department of Internal Medicine I, University Hospital Dijkzigt, Rotterdam, The Netherlands.
Synthetic human atrial natriuretic peptide (ANP) (102-126) 0.01 microgram/kg per minute or vehicle was intravenously infused for 2 h in 10 patients with insulin-dependent diabetes mellitus and microalbuminuria (albumin excretion, 20 to 200 micrograms/min) and in 10 healthy subjects. In the diabetic group, the immunoglobulin G clearance was higher, but both size index and charge index as calculated from albumin and immunoglobulin clearances were equal compared with normal values. The fractional clearances of small dextrans (< 3.6 nm) were lower in diabetics, which was compatible with a depressed hydraulic permeability (Kf). During ANP infusion, the excretion of albumin and immunoglobulin G increased in the diabetic subjects (189 +/- 12 to 521 +/- 84 and 7.1 +/- 3.5 to 21 +/- 8.1 micrograms/min, respectively; both P < 0.05) only. In the diabetics, the clearance of dextrans > 54 A increased and our calculations indicated an increase in "shut-flow" (omega o). The transcapillary escape rate of albumin, which was elevated in the diabetics at baseline, increased in the diabetic group only. Thus, ANP uncovers altered size selectivity of the filtration barrier in a phase that is otherwise characterized by charge-selective changes only. Moreover, the increased susceptibility of the glomerular capillaries in diabetics to ANP seems to be part of a more generalized capillary abnormality, because ANP also increases the transcapillary escape of albumin.
This article has been cited by other articles:
![]() |
C. J. A. M. Konings, J. P. Kooman, M. Schonck, D. G. Struijk, U. Gladziwa, S. J. Hoorntje, A. W. van der Wall Bake, F. M. van der Sande, and K. M. L. Leunissen Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study Nephrol. Dial. Transplant., April 1, 2003; 18(4): 797 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nannipieri, M. Manganiello, A. Pezzatini, A. De Bellis, G. Seghieri, and E. Ferrannini Polymorphisms in the hANP (Human Atrial Natriuretic Peptide) Gene, Albuminuria, and Hypertension Hypertension, June 1, 2001; 37(6): 1416 - 1422. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. NANNIPIERI, G. PENNO, L. PUCCI, H. COLHOUN, C. MOTTI, A. BERTACCA, L. RIZZO, L. DE GIORGIO, G. ZERBINI, R. MANGILI, et al. Pronatriodilatin Gene Polymorphisms, Microvascular Permeability, and Diabetic Nephropathy in Type 1 Diabetes Mellitus J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1530 - 1541. [Abstract] [Full Text] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673